The Japan Times - Who should get paid for nature's sequenced genes?

EUR -
AED 4.120156
AFN 72.364884
ALL 90.803943
AMD 404.528384
ANG 2.007949
AOA 1029.898611
ARS 1734.077131
AUD 1.621035
AWG 2.022213
AZN 1.906081
BAM 1.955937
BBD 2.253758
BDT 138.979752
BGN 1.960881
BHD 0.42253
BIF 3354.750342
BMD 1.121894
BND 1.432207
BOB 13.298696
BRL 6.180617
BSD 1.118979
BTN 105.025369
BWP 15.374599
BYN 3.350535
BYR 21989.116896
BZD 2.250558
CAD 1.584148
CDF 2570.258612
CHF 0.919678
CLF 0.027618
CLP 1086.958598
CNY 7.486172
CNH 7.481113
COP 3675.536984
CRC 506.835563
CUC 1.121894
CUP 26.855884
CVE 110.270772
CZK 24.341896
DJF 199.263982
DKK 7.475391
DOP 68.084777
DZD 152.624682
EGP 60.451115
ERN 16.828406
ETB 180.792892
FJD 2.526282
FKP 0.835984
GBP 0.834594
GEL 2.90596
GGP 0.835984
GHS 13.075684
GIP 0.835984
GMD 83.020251
GNF 9913.739794
GTQ 8.5506
GYD 234.582278
HKD 8.799058
HNL 30.074574
HRK 7.59411
HTG 146.670291
HUF 362.320075
IDR 20262.354178
ILS 3.543827
IMP 0.835984
INR 104.947573
IQD 1699.668985
IRR 2134162.158274
ISK 137.16221
JEP 0.835984
JMD 177.762473
JOD 0.795385
JPY 177.333286
KES 145.756022
KGS 98.109695
KHR 4566.320402
KMF 492.511066
KPW 1009.704304
KRW 1510.529067
KWD 0.348718
KYD 0.932565
KZT 502.045227
LAK 25242.608639
LBP 100206.73114
LKR 372.066107
LRD 190.233348
LSL 18.477482
LTL 3.31266
LVL 0.678622
LYD 7.190505
MAD 10.932472
MDL 20.170415
MGA 5155.101381
MKD 61.541364
MMK 2355.63634
MNT 4040.44421
MOP 9.037734
MRU 45.421187
MUR 52.76234
MVR 17.288641
MWK 1940.336146
MXN 20.784538
MYR 4.548717
MZN 71.700386
NAD 18.477574
NGN 1510.069344
NIO 41.083519
NOK 10.545145
NPR 168.037795
NZD 1.990812
OMR 0.43133
PAB 1.119079
PEN 3.85047
PGK 5.036742
PHP 70.770227
PKR 310.314733
PLN 4.385572
PYG 6994.490778
QAR 4.090487
RON 5.342349
RSD 117.608052
RUB 92.555869
RWF 1655.516162
SAR 4.218787
SBD 9.084309
SCR 16.429785
SDG 674.81632
SEK 10.994205
SGD 1.434341
SHP 0.834773
SLE 25.747516
SLL 23525.555278
SOS 639.544875
SRD 42.129343
STD 23220.934893
STN 24.501719
SVC 9.791687
SYP 14586.861783
SZL 18.395799
THB 37.502602
TJS 10.272421
TMT 3.937847
TND 3.374093
TOP 2.701251
TRY 56.347225
TTD 7.589533
TWD 36.871595
TZS 2967.406681
UAH 50.976387
UGX 4582.239831
USD 1.121894
UYU 45.123166
UZS 13422.941839
VES 1006.540888
VND 28695.797549
VUV 134.628489
WST 3.11898
XAF 655.957
XAG 0.021165
XAU 0.000272750831
XCD 3.031974
XCG 2.016742
XDR 0.793237
XOF 655.957
XPF 119.331742
YER 265.336214
ZAR 18.376058
ZMK 10098.392022
ZMW 22.743596
ZWL 361.24932
SSP 6446.193262
MXV 2.33655
  • RYCEF

    0.1000

    19.81

    +0.5%

  • VOD

    -0.2500

    16.33

    -1.53%

  • CMSC

    -0.2800

    20.12

    -1.39%

  • RBGPF

    -2.0000

    65

    -3.08%

  • RIO

    -0.2500

    94.16

    -0.27%

  • BTI

    -1.2000

    54.85

    -2.19%

  • NGG

    -0.3000

    74.94

    -0.4%

  • GSK

    -0.3500

    49.35

    -0.71%

  • BCE

    -0.4200

    20.14

    -2.09%

  • CMSD

    -0.3400

    19.93

    -1.71%

  • BP

    -0.9100

    43.52

    -2.09%

  • RELX

    0.1700

    33.24

    +0.51%

  • BCC

    -0.6200

    75.97

    -0.82%

  • AZN

    -1.9400

    164.21

    -1.18%

  • JRI

    0.0000

    10.77

    0%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

K.Abe--JT